REGENXBIO

Develops adeno-associated virus gene therapies for rare and chronic diseases.

regenxbio.comBiotechnology, Pharmaceuticals394 employeesUS
PublicFounded 2008Gene therapy developmentAdeno-associated virus engineeringBiopharmaceutical manufacturingClinical research operationsTherapeutic drug discovery
Showing 6 matching jobs
Title
Senior Medical Science Liaison - DMD/Neuromuscular (South)
Full Time · $170K-$230K · 3+ YOE
United States · Remote
(Sr.) Director, GCP & GLP QA
Full Time · $190K-$330K · 10+ YOE
Rockville, Maryland, United States · Hybrid
Senior Medical Science Liaison - Retina
Full Time · $170K-$230K · 3+ YOE
United States · Remote
Senior Director, Global Program Development Lead - DMD/Neuromuscular
Full Time · $235K-$335K · 8+ YOE
Rockville, Maryland, United States · Onsite
Senior Medical Science Liaison - DMD/Neuromuscular (Northeast)
Full Time · $170K-$230K · 3+ YOE
United States · Remote
Senior Director/Director, Medical Science Liaisons (Neuromuscular/DMD)
Full Time · 5+ YOE
United States · Remote

About REGENXBIO

Activities
Gene therapy developmentAdeno-associated virus engineeringBiopharmaceutical manufacturingClinical research operationsTherapeutic drug discovery
HeadquartersUS
Industries
BiotechnologyPharmaceuticals
NameREGENXBIO
Employees394
TypePublic
TaglineDevelops adeno-associated virus gene therapies for rare and chronic diseases.
Founded2,008
Websiteregenxbio.com
Stock ExchangeNASDAQ
Stock SymbolRGNX